Login / Signup

Natural history and genotype-phenotype correlations in 72 individuals with SATB2-associated syndrome.

Yuri A ZarateConstance L Smith-HicksCarol GreeneMary-Alice AbbottVictoria M SiuAmy R U L CalhounArti PandyaChumei LiElizabeth A SellarsJulie KaylorKatherine BosankoLouisa KalsnerAlice BasingerAnne M SlavotinekHazel PerryMargarita SaenzMarta SzybowskaLouise C WilsonAjith KumarCaroline BrainMeena BalasubramanianHolly DubbsXilma R Ortiz-GonzalezElaine ZackaiQuinn SteinCynthia M PowellSamantha A Schrier VerganoAllison BrittAngela SunWendy SmithE Martina BebinJonathan PickerAmelia KirbyHailey PinzHannah BombeiSonal MahidaJulie S CohenAli FatemiHilary J VernonRebecca McClellanLeah R FlemingBrittney KnyszekMichelle SteinrathsCruz Velasco GonzalezAnita E BeckKatie L Golden-GrantAlena EgenseAditi ParikhChantalle RaimondiBrad AngleWilliam AllenSuzanna SchottAdi AlgrabliNathaniel H RobinJoseph W RayDavid B EvermanMichael J GambelloWendy K Chung
Published in: American journal of medical genetics. Part A (2018)
SATB2-associated syndrome (SAS) is an autosomal dominant disorder characterized by significant neurodevelopmental disabilities with limited to absent speech, behavioral issues, and craniofacial anomalies. Previous studies have largely been restricted to case reports and small series without in-depth phenotypic characterization or genotype-phenotype correlations. Seventy two study participants were identified as part of the SAS clinical registry. Individuals with a molecularly confirmed diagnosis of SAS were referred after clinical diagnostic testing. In this series we present the most comprehensive phenotypic and genotypic characterization of SAS to date, including prevalence of each clinical feature, neurodevelopmental milestones, and when available, patient management. We confirm that the most distinctive features are neurodevelopmental delay with invariably severely limited speech, abnormalities of the palate (cleft or high-arched), dental anomalies (crowding, macrodontia, abnormal shape), and behavioral issues with or without bone or brain anomalies. This comprehensive clinical characterization will help clinicians with the diagnosis, counseling and management of SAS and help provide families with anticipatory guidance.
Keyphrases
  • palliative care
  • risk factors
  • multiple sclerosis
  • white matter
  • hepatitis c virus
  • postmenopausal women
  • subarachnoid hemorrhage